CDK4/6/HDAC-IN-1 (Compound N14) is a dual-target inhibitor of CDK4/6 and HDAC, with IC50 values of 7.23 nM for CDK4, 13.20 nM for CDK6, 55.66 nM for HDAC1, and 48.38 nM for HDAC6. It induces apoptosis and G0/G1 phase arrest through the HDAC-p21-CDK signaling pathway and can inhibit hepatocellular carcinoma.
Molecular Weight:
665.742
Formula:
C35H39N9O5
Target:
CDK|||HDAC|||Apoptosis
T204833
* VAT and and shipping costs not included. Errors and price changes excepted
